- Report
- September 2023
- 100 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- February 2024
- 185 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- September 2022
- 162 Pages
Global
From €3422EUR$3,600USD£2,875GBP
- Report
- September 2022
- 55 Pages
North America
From €1426EUR$1,500USD£1,198GBP
- Report
- September 2022
- 63 Pages
Asia Pacific
From €1426EUR$1,500USD£1,198GBP
- Report
- September 2022
- 63 Pages
Middle East, Africa
From €1426EUR$1,500USD£1,198GBP
- Report
- September 2022
- 63 Pages
Europe
From €1426EUR$1,500USD£1,198GBP
- Report
- June 2023
- 180 Pages
Global
€4368EUR$4,595USD£3,670GBP
The Dry Eye Treatment Devices market is a subset of the Optical Disorders Drugs market, which focuses on the development and sale of products to treat dry eye syndrome. Dry eye syndrome is a condition in which the eyes do not produce enough tears, or the tears evaporate too quickly, leading to discomfort and vision problems. Treatment devices are designed to supplement the natural tear production of the eye, providing relief from symptoms. These devices can be either mechanical or chemical, and can be used in conjunction with other treatments such as eye drops or ointments.
The Dry Eye Treatment Devices market is highly competitive, with a variety of products available from different manufacturers. Companies in the market include Allergan, Bausch + Lomb, Johnson & Johnson Vision Care, Novartis, and Shire. Show Less Read more